5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.15▲ | 8.17▲ | 8.16▲ | 8.12▲ | 7.96▲ |
MA10 | 8.15▲ | 8.16▲ | 8.14▲ | 7.98▲ | 8.14▲ |
MA20 | 8.16▲ | 8.15▲ | 8.14▲ | 7.85▲ | 8.39▼ |
MA50 | 8.15▲ | 8.15▲ | 8.04▲ | 8.18▼ | 7.94▲ |
MA100 | 8.16▲ | 8.01▲ | 7.89▲ | 8.34▼ | 6.70▲ |
MA200 | 8.15▲ | 7.87▲ | 7.76▲ | 7.98▲ | 8.25▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.002▲ | -0.006▼ | 0.074▲ | -0.106▼ |
RSI | 53.277▲ | 52.911▲ | 54.860▲ | 56.184▲ | 51.055▲ |
STOCH | 27.350 | 75.969 | 49.721 | 84.263▲ | 35.678 |
WILL %R | -53.846 | -29.545 | -49.180 | -18.987▲ | -52.941 |
CCI | 10.853 | 37.342 | 23.698 | 103.151▲ | -27.621 |
▲ MACD | $TG MACD(12,26,9) Crossed Above Zero | Set Alert |
Tuesday, September 16, 2025 05:32 AM
A look at the shareholders of Tredegar Corporation (NYSE:TG) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 67% ownership. In other ...
|
Wednesday, September 10, 2025 12:30 AM
BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...
|
Monday, September 08, 2025 04:44 AM
TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/09/25 | 8.01 | 8.26 | 8.01 | 8.17 | 58,100 |
17/09/25 | 8.10 | 8.32 | 8.01 | 8.01 | 99,500 |
16/09/25 | 8.21 | 8.21 | 8.045 | 8.15 | 63,451 |
15/09/25 | 8.03 | 8.265 | 8.03 | 8.23 | 114,147 |
12/09/25 | 8.00 | 8.05 | 7.934 | 8.03 | 47,803 |
11/09/25 | 7.77 | 8.01 | 7.77 | 8.00 | 69,564 |
10/09/25 | 7.75 | 7.83 | 7.75 | 7.79 | 57,000 |
09/09/25 | 7.90 | 7.90 | 7.64 | 7.72 | 77,508 |
08/09/25 | 7.88 | 7.94 | 7.74 | 7.88 | 107,500 |
05/09/25 | 7.73 | 7.89 | 7.70 | 7.84 | 65,000 |
|
|
||||
|
|
||||
|
|